Stay updated with breaking news from Anti Microbial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and...
/PRNewswire/ -- The "PCR Markets. Forecasts for qPCR, dPCR, Singleplex & Multiplex Markets and by Application, Product and Place. With Executive and Consultant...
/PRNewswire/ -- The "Syndromic Multiplex Diagnostic Markets with COVID-19 Impacts. Strategies and Trends, Forecasts by Syndrome (Respiratory, Sepsis, GI Etc.),...
Get latest articles and stories on Business at LatestLY. Bengaluru (Karnataka) [India], February 7: Bengaluru-based startup CrisprBits Private Limited, has developed OmiCrisp, a CRISPR based testing platform for rapid diagnosis and surveillance of SARS-CoV2. The CRISPR based test not only detects the virus, but also distinguishes variants of Omicron lineage from other previously known variants of concern. Business News | CrisprBits' OmiCrisp Tracks Omicron-derived JN.1 Variant in Sewage Samples in Bengaluru.
Dublin, May 12, 2023 (GLOBE NEWSWIRE) -- The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With...